 |
Equitable Distribution of COVID-19 Vaccines Session 2 -
Wednesday, November 18, 5-6 p.m. EST
Meet online with community stakeholders, researchers, and Massachusetts health leaders to discuss how to work together to protect us from COVID-19. Join us for session 2 of a 2-part series to understand how state guidelines for equitable vaccine distribution will be implemented locally to address vaccine hesitancy. We hope you will contribute your ideas! Read more.
|
|
|
|
|
Early Stage Research Career Development Program -
Application Due Date: November 25, 2020
The Early Stage Research Career Development Program will provide a roadmap and targeted guidance for senior post-doctoral fellows and junior faculty (both MD and PhD) committed to launching an independent research career.
|
|
|
|
|
COVID-19 Vaccine Hesitancy Application - Application Due Date: December 1, 2020 |
This funding opportunity encourages researchers to submit a pilot project grant application that will identify, develop, test, evaluate and/or refine strategies in order to advance the preparedness of government agencies, healthcare systems, and community organizations in influencing the support of COVID-19 vaccine distribution among populations at the greatest risk of spread or exposure to the virus.
|
|
|
|
CTSI Makes Pandemic Vouchers Available - Application Due Date: December 31, 2020 |
Vouchers are designed to support
the short-term needs of research investigators whose time to conduct research has been negatively impacted by pandemic-related childcare/ eldercare/family care and other home-related responsibilities. Assistance is intended to allow investigators to complete a study, submit publications, generate preliminary data necessary for publishing findings, or write research grants. Start the Pandemic Voucher Application Here.
|
|
|
|
|
New Funding Opportunities |
|
|
|
|
Understanding the Cellular and Molecular Mechanisms of Gastroparesis in Adults and Children (R01 Clinical Trial Not Allowed)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
|
Exploring the Scientific Value of Existing or New Sepsis Human Biospecimen Collections (R21/R33 - Clinical Trial Not Allowed)
National Institute of General Medical Sciences (NIGMS)
|
|
|
|
Urgent Phase I/II Clinical Trials to Repurpose Existing Therapeutic Agents to Treat COVID-19 Sequelae (U01 Clinical Trial Required)
National Center for Advancing Translational Sciences (NCATS)
|
Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R21 Clinical Trial Required)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
|
|
|
|
Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19 (R01 - Clinical Trial Optional)
National Institute of Mental Health (NIMH)
|
National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
National Cancer Institute (NCI)
|
|
|
|
|
Due: November 24, 2020
Funding: $250,000 per year
Project period: Up to 2 years
Purpose: Build the evidence base about how national, state, and local policies can improve racial equity in health and well-being in the United States.
|
|
|
|
Due: November 30, 2020
Funding: $100,000
Project period: 1 year
Purpose: For early-career clinical scientists who hold a medical degree and are interested in acquiring the knowledge and skills related to clinical trial design and execution from the perspective of the pharmaceutical industry.
|
|
|
|
|
Due: December 10, 2020
Funding: $50,000
Project period: 2 years
Purpose: Help stimulate and inform important public policy debates around healthy air and lung disease.
|
|
|
|
Due: January 1, 2021
Funding: $45,000
Project period:1 year
Purpose: Provide opportunities for junior or non-tenured scholars (within seven years of receiving their PhD) from all academic disciplines to pursue cutting-edge projects on retirement or disability issues.
|
|
|
|
|
Can Autoimmune Antibodies Explain Blood Clots in COVID-19?
A new study suggests that COVID-19, doesn’t act alone in causing blood clots. The virus seems to unleash mysterious antibodies that mistakenly attack the body’s own cells to cause clots. Read More.
|
|
|
|
|
Promising Interim Results From Clinical Trial of NIH-Moderna COVID-19 Vaccine
This interim review of data suggests that the vaccine is safe and effective at preventing symptomatic COVID-19 in adults. Read More.
|
|
|
|
|
N3C Mobilizes Patient Data to Study
COVID-19
Built and launched in just a few short months, the N3C was established with researchers from more than 300 institutions with shared interests of analyzing large-scale COVID-19 data.
|
|
|
|
|
Cardiac Arrest Treatment That Uses Life Support Machine Boosts Survival
The treatment program involving the life support machine called extracorporeal membrane oxygenation (ECMO) proved so much more effective than the standard treatment for this usually fatal condition that the trial was stopped early. Read More.
|
|
|
|
|
NCI Cancer Moonshot Seminar Series: Drug Resistance Network - November 19, 2020; 12:00 p.m. - 1:00 p.m. EST
This seminar series showcases and enhances discussions and collaborations related to research from different Cancer Moonshot initiatives. Read More.
|
|
|
|
|
Systemic Immunogenicity Considerations for AAV-Mediated Gene Therapy Workshop
November 30, 2020 - December 1, 2020;
12:00 a.m. - 12 p.m. EST
This meeting will bring together scientists, therapeutic developers & patient representatives to focus on immunogenicity issues related to the systemic administration of AAV gene therapy products and solutions.
|
|
|
|
|
50 Years of Evidence-Based Diagnosis,
Prevention, and Treatment Research - November 30, 2020 - December 1, 2020; 1:00 p.m. EST
Find the agenda and links to the NIH
webcast for each day here.
|
|
|
|
|
Wearables & Biosensors for Environmental and Human Health - December 2, 2020;
4:00 p.m. - 5:30 p.m. EST
This event unites researchers from diverse fields to explore how new biosensing technology and data analytics can drive new hypotheses & solutions for better health.
|
|
|
|
|
|
Accelerating Discoveries Towards Better Health
|
bu.edu/ctsi | ncats.nih.gov
|
|
|
|
|
|
|
